The role of ATM in breast cancer development
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Ataxia Telangiectasia Mutated Proteins MeSH
- DNA-Binding Proteins physiology MeSH
- Humans MeSH
- Mutation MeSH
- Tumor Suppressor Proteins physiology MeSH
- Breast Neoplasms etiology MeSH
- Protein Serine-Threonine Kinases physiology MeSH
- Cell Cycle Proteins physiology MeSH
- Ataxia Telangiectasia genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- ATM protein, human MeSH Browser
- Ataxia Telangiectasia Mutated Proteins MeSH
- DNA-Binding Proteins MeSH
- Tumor Suppressor Proteins MeSH
- Protein Serine-Threonine Kinases MeSH
- Cell Cycle Proteins MeSH
Complete or partial inability to sense and repair DNA damage increases the risk of developing cancer. The ataxia telangiectasia mutated (ATM) protein kinase has a crucial role in response to DNA double-strand breaks. Hereditary mutations in the ATM gene are the cause of a rare genomic instability syndrome ataxia telangiectasia (AT) characterized, among others, by elevated cancer risk. Although clear in homozygotes, numerous studies have failed to find a link between heterozygotes and cancer. However, there is increasing evidence that ATM heterozygotes have an increased risk of developing breast cancer. First, epidemiological studies conferred an increased risk of breast cancer among AT relatives. Second, in vitro studies of heterozygous cells provide strong evidence of hyperradiosensitivity. Third, some clinical studies found an increased frequency of ATM mutations among high-risk breast cancer families.
References provided by Crossref.org
Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma
Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients